Isolation of a human monoclonal antibody specific for the receptor binding domain of SARS-CoV-2 using a competitive phage biopanning strategy

The infection of the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused more than 200 000 deaths, but no vaccine or therapeutic monoclonal antibody is currently available. SARS-CoV-2 relies on its spike protein, in particular the receptor-binding domain (RBD),...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Xin, Li, Lingfang, Lin, Jing, Li, Xinlei, Liu, Bin, Kong, Yang, Zeng, Shunze, Du, Jianhua, Xiao, Huahong, Zhang, Tao, Zhang, Shelin, Liu, Jianghai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197610/
https://www.ncbi.nlm.nih.gov/pubmed/33912790
http://dx.doi.org/10.1093/abt/tbaa008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197610/
https://www.ncbi.nlm.nih.gov/pubmed/33912790
http://dx.doi.org/10.1093/abt/tbaa008

Ejemplares similares